Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Rheumatology

Rheumatology for May/June 2019

OA is Underrepresented in Medical Literature,

Booster Vaccines Safe in Children on Immunosuppressive Drugs,

Efforts toward producing CNO/CRMO classification criteria show first results,

Cardiovascular events in U.S. RA patients fall to non-RA level,

Lowering hyperuricemia improved endothelial function but failed as an antihypertensive,

More must reads

Rheumatology for March/April 2019

Childhood-Onset SLE Rate Higher in Children Born in Winter,

Fall Prevention Should Be High Priority in SLE patients,

‘Type II’ SLE Assessment Catches What Matters to Patients,

Rituximab Does Not Improve Fatigue Symptoms of ME/CFS,

Abatacept Appears Safe for RA Patients with COPD,

More must reads

Rheumatology for January/February 2019

List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598

Ehlers-Danlos syndrome: Increased IUGR risk reported, Nicholls-Dempsey L et al. Am J Obstet Gynecol. 2019 Jan;220(1):S381-382. Abstract 574
More must reads

Rheumatology for July/August 2018

Screening for Osteoporosis to Prevent Fractures, JAMA; ePub 2018 Jun 26; US Preventive Services Task Force
More must reads

Rheumatology for May/June 2018

Psychological Interventions & Chronic Pain Reduction, JAMA Intern Med; ePub 2018 May 7; Niknejad, et al
More must reads

Pages